Intellectual Property

The technology, covered by a number of worldwide patents at various prosecution stages, has been exclusively licensed from Rutgers University to Mito Biopharma, LLC. Mito BioPharma has exclusive worldwide rights to develop, market, and sell the patent technology. A key patent has been recently issued in the US (March 2019).  

Mito Biopharma has contracted Pepper Hamilton LLP as its sole patent agent.